Skip to content
Business Segments · Total assets of reportable segments

Cardiovascular — Total assets of reportable segments

Boston Scientific Cardiovascular — Total assets of reportable segments increased by 3.2% to $8.25B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 11.3%, from $7.41B to $8.25B.

Analysis

StatementSegment
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ4 2019
Last reportedQ1 2026May 1, 2026

How to read this metric

An increase suggests expansion of the segment's asset base, potentially indicating future growth capacity or recent acquisitions.

Detailed definition

This metric represents the total book value of assets directly employed by the cardiovascular segment to generate revenu...

Peer comparison

Comparable to 'Segment Assets' reported by diversified industrial and healthcare companies.

Metric ID: bsx_segment_cardiovascular_total_assets_of_reportable_segments

Historical Data

9 periods
 Q4 '21Q4 '22Q4 '23Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$4.42B$5.21B$5.99B$7.08B$7.41B$7.5B$7.8B$8B$8.25B
QoQ Change+17.8%+15.0%+18.3%+4.6%+1.1%+4.0%+2.6%+3.2%
YoY Change+17.8%+15.0%+18.3%+12.9%+11.3%
Range$4.42B$8.25B
CAGR+36.7%
Avg YoY Growth+15.1%
Median YoY Growth+15.0%
Current Streak8+ quarters growth

Frequently Asked Questions

What is Boston Scientific's cardiovascular — total assets of reportable segments?
Boston Scientific (BSX) reported cardiovascular — total assets of reportable segments of $8.25B in Q1 2026.
How has Boston Scientific's cardiovascular — total assets of reportable segments changed year-over-year?
Boston Scientific's cardiovascular — total assets of reportable segments increased by 11.3% year-over-year, from $7.41B to $8.25B.
What does cardiovascular — total assets of reportable segments mean?
The total value of assets dedicated to the cardiovascular business segment.